Tag Archives: PATIENTS

Lilly’s Cyramza (ramucirumab) Becomes First FDA-Approved Biomarker-Driven Therapy in Patients with Hepatocellular Carcinoma

Print this page INDIANAPOLIS, May 13, 2019 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug Administration (FDA) has approved Cyramza (ramucirumab injection, 10 mg/mL solution), as a single agent, for the treatment of patients with hepatocellular carcinoma (HCC) who have an alpha-fetoprotein (AFP) of ≥400 ng/mL and… Read More »

Viewpoints: Social Media Giants Finally Get Smart, Block Dangerous Antivaccine Misinformation; Patients Needing Cheaper Insulin End Up Being Winners

Opinion writers weigh in on these health topics and others. The Philadelphia Inquirer/Philly.com: Facebook, Twitter Are Blocking Dangerous Antivaccine Posts. It’s About Time  In recent weeks, Pinterest, YouTube, Facebook, and Amazon have done something previously thought unimaginable—they’ve censored potentially dangerous health information, at last addressing a problem that started in the late 1990s. …Although marginalized,… Read More »